Trinity Biotech plc (TRIB) Misses Q4 EPS by 2c

Trinity Biotech plc (NASDAQ: TRIB) reported Q4 EPS of $0.18, $0.02 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $26 million versus the consensus estimate of $27 million.

For earnings history and earnings-related data on Trinity Biotech plc (TRIB) click here.

You May Also Be Interested In

• Midday movers: Morgan Stanley, UnitedHealth rise; Tesla falls
• Barrick Gold (GOLD) reported preliminary Q1 production of 940 thousand ounces of gold
• Itau BBA Reiterates Outperform Rating on Lojas Renner SA (LREN3:BZ) (LRENY), Maintain Top Pick